Cargando…

Out‐of‐pocket costs and burden among rural breast cancer survivors

Little is known about out‐of‐pocket (OOP) costs incurred for medical and health needs by rural breast cancer survivors and what factors may be associated with higher OOP costs and the associated economic burden. Data were examined for 432 survivors participating in the Rural Breast Cancer Survivor I...

Descripción completa

Detalles Bibliográficos
Autores principales: Pisu, Maria, Azuero, Andres, Benz, Rachel, McNees, Patrick, Meneses, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345680/
https://www.ncbi.nlm.nih.gov/pubmed/28229562
http://dx.doi.org/10.1002/cam4.1017
_version_ 1782513763976478720
author Pisu, Maria
Azuero, Andres
Benz, Rachel
McNees, Patrick
Meneses, Karen
author_facet Pisu, Maria
Azuero, Andres
Benz, Rachel
McNees, Patrick
Meneses, Karen
author_sort Pisu, Maria
collection PubMed
description Little is known about out‐of‐pocket (OOP) costs incurred for medical and health needs by rural breast cancer survivors and what factors may be associated with higher OOP costs and the associated economic burden. Data were examined for 432 survivors participating in the Rural Breast Cancer Survivor Intervention trial. OOP costs were collected using the Work and Finances Inventory survey at baseline and four assessments every 3 months. Mean and median OOP costs and burden (percent of monthly income spent on OOP costs) were reported and factors associated with OOP costs and burden identified with generalized linear models fitted with over‐dispersed gamma distributions and logarithmic links (OOP costs) and with beta distributions with logit link (OOP burden). OOP costs per month since the end of treatment were on average $232.7 (median $95.6), declined at the next assessment point to $186.5 (median $89.1), and thereafter remained at that level. Mean OOP burden was 9% at baseline and between 7% and 8% at the next assessments. Factors suggestive of contributing to higher OOP costs and OOP burden were the following: younger age, lower income, time in survivorship from diagnosis, and use of supportive services. OOP costs burden rural breast cancer survivors, particularly those who are younger and low income. Research should investigate the impact of OOP costs and interventions to reduce economic burden.
format Online
Article
Text
id pubmed-5345680
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-53456802017-03-14 Out‐of‐pocket costs and burden among rural breast cancer survivors Pisu, Maria Azuero, Andres Benz, Rachel McNees, Patrick Meneses, Karen Cancer Med Clinical Cancer Research Little is known about out‐of‐pocket (OOP) costs incurred for medical and health needs by rural breast cancer survivors and what factors may be associated with higher OOP costs and the associated economic burden. Data were examined for 432 survivors participating in the Rural Breast Cancer Survivor Intervention trial. OOP costs were collected using the Work and Finances Inventory survey at baseline and four assessments every 3 months. Mean and median OOP costs and burden (percent of monthly income spent on OOP costs) were reported and factors associated with OOP costs and burden identified with generalized linear models fitted with over‐dispersed gamma distributions and logarithmic links (OOP costs) and with beta distributions with logit link (OOP burden). OOP costs per month since the end of treatment were on average $232.7 (median $95.6), declined at the next assessment point to $186.5 (median $89.1), and thereafter remained at that level. Mean OOP burden was 9% at baseline and between 7% and 8% at the next assessments. Factors suggestive of contributing to higher OOP costs and OOP burden were the following: younger age, lower income, time in survivorship from diagnosis, and use of supportive services. OOP costs burden rural breast cancer survivors, particularly those who are younger and low income. Research should investigate the impact of OOP costs and interventions to reduce economic burden. John Wiley and Sons Inc. 2017-02-23 /pmc/articles/PMC5345680/ /pubmed/28229562 http://dx.doi.org/10.1002/cam4.1017 Text en © 2017 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Cancer Research
Pisu, Maria
Azuero, Andres
Benz, Rachel
McNees, Patrick
Meneses, Karen
Out‐of‐pocket costs and burden among rural breast cancer survivors
title Out‐of‐pocket costs and burden among rural breast cancer survivors
title_full Out‐of‐pocket costs and burden among rural breast cancer survivors
title_fullStr Out‐of‐pocket costs and burden among rural breast cancer survivors
title_full_unstemmed Out‐of‐pocket costs and burden among rural breast cancer survivors
title_short Out‐of‐pocket costs and burden among rural breast cancer survivors
title_sort out‐of‐pocket costs and burden among rural breast cancer survivors
topic Clinical Cancer Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345680/
https://www.ncbi.nlm.nih.gov/pubmed/28229562
http://dx.doi.org/10.1002/cam4.1017
work_keys_str_mv AT pisumaria outofpocketcostsandburdenamongruralbreastcancersurvivors
AT azueroandres outofpocketcostsandburdenamongruralbreastcancersurvivors
AT benzrachel outofpocketcostsandburdenamongruralbreastcancersurvivors
AT mcneespatrick outofpocketcostsandburdenamongruralbreastcancersurvivors
AT meneseskaren outofpocketcostsandburdenamongruralbreastcancersurvivors